Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

multi-epitope anti-folate receptor peptide vaccine TPIV 200

A peptide vaccine containing five immunogenic peptide epitopes of the human folate receptor 1 (FOLR1; FR-alpha), with potential immunomodulating and antineoplastic activities. Upon intradermal administration, multi-epitope anti-folate receptor peptide vaccine TPIV 200 may induce a cytotoxic T-lymphocyte (CTL) response against FR-alpha-overexpressing tumor cells. FR-alpha is a high-affinity folate-binding protein and a member of the folate receptor family; this receptor is overexpressed in various cancer cell types.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:TPIV 200 vaccine
TPIV200/huFR-1
Code name:TPIV 200
TPIV-200
TPIV200
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search